FDG-PET imaging has become an accepted, reimburseable approach for diagnosing Alzheimer's and other neurodegenerative diseases.
CONTEXT: FDG-PET imaging has become an accepted, reimburseable approach for diagnosing Alzheimer's and other neurodegenerative diseases. No clinically practical method has been proven to predict rate of cognitive degeneration of individuals, however. Dr. Daniel Silverman, an associate professor of molecular medicine and pharmacology at the University of California, Los Angeles, is developing a way to quantify FDG-PET data to predict the rate of cognitive decline.
RESULTS: Silverman and Dr. Gary Small, director of the UCLA Center on Aging, studied 25 subjects using formal neuropsychologic tests and standard clinical brain scans at baseline and two years later. Brain metabolism for each subject was automatically analyzed, using a standardized region of interest (sROI) approach that examines 240 regions and groups them into 42 regional clusters. As the most common types of neurodegenerative processes involving progressively diminished language and memory are associated with posterior-predominant hypometabolism, an index was constructed to capture the posterior/anterior gradient reflected by loss of metabolism in some posterior regional clusters.
FDG-PET predicted the rate of cognitive decline in some subgroups of patients within 20% of the actual rate of change.
IMAGE: Standardized ROI approach automatically quantifies loss of metabolism in some posterior regional clusters (planes 22, 24, and 32) relative to metabolism of some better preserved regional clusters in prefrontal cortex (plane 20) in individual subjects.
IMPLICATIONS: This study demonstrated the feasibility of using an automated analysis of FDG-PET scans in a clinical setting to predict rates of cognitive decline.
"It's a promising start," said Dr. Silverman. "But research needs to be done with much larger groups of subjects."
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.